Not yet recruiting
Chronic obstructive pulmonary disease
Not yet recruitingStudy of Two Doses of EXPD-101 vs Placebo for Reducing COPD Exacerbations in Adults with Chronic Obstructive Pulmonary Disease
Investigational
Study of Two Doses of EXPD-101 vs Placebo for Reducing COPD Exacerbations in Adults with Chronic Obstructive Pulmonary Disease
Investigational
- Disease:Chronic obstructive pulmonary disease
- Substances:EXPD-101
Countries:
Bulgaria
Bulgaria- Participants:18–64 years · 65+ years
- Substances:EXPD-101



